Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

7.1%

1 terminated out of 14 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

14%

2 trials in Phase 3/4

Results Transparency

50%

3 of 6 completed with results

Key Signals

3 with results86% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (11)
P 3 (2)

Trial Status

Completed6
Unknown2
Active Not Recruiting2
Enrolling By Invitation1
Recruiting1
Terminated1

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (14)

Research Network

Activity Timeline